Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T39403 |
Avotaciclib
BEY1107,Avotaciclib |
CDK | Cell Cycle/Checkpoint |
Avotaciclib (BEY1107) 是一种有效和具有口服活性的 cyclin dependent kinase 1 (CDK1) 抑制剂。Avotaciclib 可用于研究局部晚期或转移性胰腺癌。 | |||
T78137 |
Avotaciclib hydrochloride
BEY1107 hydrochloride |
CDK | Cell Cycle/Checkpoint |
Avotaciclibhydrochloride是Avotaciclib的盐酸盐形式,具有抑制CDK1的作用。适用于治疗CDK1异常高表达的特定癌症类型,例如胰腺癌。 | |||
T39405 |
Avotaciclib trihydrochloride
BEY1107 trihydrochloride |
Others | Others |
Avotaciclib trihydrochloride, also known as BEY1107, is a highly effective and orally active inhibitor of cyclin dependent kinase 1 (CDK1). This compound is particularly valuable for researching locally advanced or metastatic pancreatic cancer. |